Page last updated: 2024-08-23

amitraz and paclitaxel

amitraz has been researched along with paclitaxel in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Adelaïde, J; Bertucci, F; Carbuccia, N; Chaffanet, M; Dalenc, F; Garnier, S; Goncalves, A; Guille, A; Isambert, N; Levy, C; Mamessier, E; Pakradouni, J; Robert, M; Sabatier, R; Sfumato, P; Vicier, C	1

Trials

1 trial(s) available for amitraz and paclitaxel

Article	Year
Circulating tumor DNA predicts efficacy of a dual AKT/p70S6K inhibitor (LY2780301) plus paclitaxel in metastatic breast cancer: plasma analysis of the TAKTIC phase IB/II study. Molecular oncology, 2022, Volume: 16, Issue:10 Topics: Angiogenesis Inhibitors; Biomarkers, Tumor; Breast Neoplasms; Circulating Tumor DNA; Female; Humans; Mutation; Paclitaxel; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Ribosomal Protein S6 Kinases, 70-kDa; Toluidines	2022

Article

Year

Circulating tumor DNA predicts efficacy of a dual AKT/p70S6K inhibitor (LY2780301) plus paclitaxel in metastatic breast cancer: plasma analysis of the TAKTIC phase IB/II study.

Molecular oncology, 2022, Volume: 16, Issue:10

Topics: Angiogenesis Inhibitors; Biomarkers, Tumor; Breast Neoplasms; Circulating Tumor DNA; Female; Humans; Mutation; Paclitaxel; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Ribosomal Protein S6 Kinases, 70-kDa; Toluidines

2022